Women taking the low dose also experienced fewer side effects, such as headache, nausea, breast tenderness, and vaginal bleeding, than women on higher doses.
Women often perceive that the risks associated with taking estrogen outweigh the benefits.
Recent studies show that most menopausal women either do not take estrogen, fail to fill their prescription or stop taking estrogen before one year, which could place their long-term health in jeopardy. The two-year study was published in the December issue of Archives of Internal Medicine and found that a daily oral dose of 0.3 mg Estratab Tablets not only provided relief from vasomotor symptoms of menopause, such as hot flashes and night sweats, but also increased bone mass in the hip and spine, a predictive measure of reduction in the number of fractures that may occur as a woman ages. The 0.3 mg Estratab Tablets dose is half the dose of the animal-based estrogen normally prescribed by physicians for osteoporosis prevention. Approximately one-third of the women were hysterectomised. Each patient also received a daily supplement of 1,000 mg of calcium.